- Home
- ROIV vs PKG Comparison
ROIV vs PKG Comparison
Compare ROIV & PKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | PKG |
|---|---|---|
| Founded | 2014 | 1867 |
| Country | United Kingdom | United States |
| Employees | N/A | 13600 |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.0B | 19.0B |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ROIV | PKG |
|---|---|---|
| Price | $30.28 | $228.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $28.94 | ★ $232.38 |
| AVG Volume (30 Days) | ★ 5.9M | 566.5K |
| Earning Date | 05-28-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | $8,260,000.00 | ★ $8,989,300,000.00 |
| Revenue This Year | N/A | $13.32 |
| Revenue Next Year | $744.61 | $4.61 |
| P/E Ratio | ★ N/A | $117.70 |
| Revenue Growth | N/A | ★ 7.23 |
| 52 Week Low | $10.71 | $185.77 |
| 52 Week High | $32.79 | $249.51 |
Technical Indicators
Market Signals| Indicator | ROIV | PKG |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 58.66 |
| Support Level | $27.44 | $202.02 |
| Resistance Level | $32.79 | $229.58 |
| Average True Range (ATR) | 0.87 | 6.19 |
| MACD | 0.01 | 0.55 |
| Stochastic Oscillator | 86.99 | 96.15 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PKG Packaging Corporation of America
Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.